8-K Announcements
6Material company update
Apr 20, 2026·SEC
Material company update
Dec 23, 2025·SEC
Material company update
Nov 7, 2025·SEC
OneMedNet Corporation(ONMD)Earnings, Financials & Key Ratios
ONMD•NASDAQ
Price updated Jun 19, 2026
AboutOneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.Show more
- Revenue$1M+111.4%
- EBITDA-$10M-0.6%
- Net Income-$3M+72.3%
- EPS (Diluted)-0.06+83.3%
- Gross Margin-37.01%+15.3%
- EBITDA Margin-706.55%+52.4%
- Operating Margin-711.33%+52.4%
- Net Margin-206.11%+86.9%
ONMD Key Insights
OneMedNet Corporation (ONMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 10.5%
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 6 (bottom 6%)
- ✗Shares diluted 58.7% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ONMD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ONMD Price & Volume
OneMedNet Corporation (ONMD) stock price & volume — 10-year historical chart
Loading chart...
ONMD Growth Metrics
OneMedNet Corporation (ONMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years10.52%
3 Years5.63%
TTM147.93%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM66.22%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM87.87%
Return on Capital
10 Years-
5 Years-
3 Years-
Last Year-
ONMD Recent Earnings
OneMedNet Corporation (ONMD) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 20, 2026Metric
Actual
Est
EPS
$0.04
—
Rev
$96,000
—
Q2 2026
May 15, 2026Metric
Actual
Est
EPS
$0.04
—
Rev
$96,000
—
Q2 2026
Mar 30, 2026Metric
Actual
Est
EPS
$0.07
—
Rev
$891,000
—
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.01
—
Rev
$177,000
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 20, 2026 | $0.04 | $96,000 |
| Q2 2026 | May 15, 2026 | $0.04 | $96,000 |
| Q2 2026 | Mar 30, 2026 | $0.07 | $891,000 |
| Q4 2025 | Nov 14, 2025 | $0.01 | $177,000 |
Based on last 12 quarters of dataView full earnings history →
ONMD Peer Comparison
OneMedNet Corporation (ONMD) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 HCAT | 128.58M | 1.74 | -0.68 | 1.48% | -87.69% | -99.78% | 0.70 | |
 DOCS | 3.83B | 20.46 | 20.88 | 13.05% | 30.4% | 19.36% | 0.01 | |
 PHVS | 2.15B | 32.80 | -9.60 | -67.38% | 0.00 | |||
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 MTEX | 10.46M | 5.42 | -0.68 | -8.34% | -11.97% | -23.83% | ||
 VEEV | 24.9B | 153.30 | 28.18 | 16.34% | 28.37% | 13.36% | 0.01 | |
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 |
Compare ONMD vs Peers
OneMedNet Corporation (ONMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ONMD Income Statement
OneMedNet Corporation (ONMD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|
Sales/Revenue | 824.03K | 1.09M | 1.15M | 1.02M | 643K | 1.36M | 1.32M |
Revenue Growth % | - | 32.49% | 5.61% | -11.45% | -37.02% | 111.35% | 147.93% |
Cost of Goods Sold | 611.66K | 1.21M | 1.51M | 1.15M | 924K | 1.86M | 2M |
COGS % of Revenue | 74.23% | 110.39% | 131.22% | 112.63% | 143.7% | 137.01% | - |
Gross Profit | 212.37K▲ 0% | -113.41K▼ 153.4% | -360K▼ 217.4% | -129K▲ 64.2% | -281K▼ 117.8% | -503K▼ 79.0% | -678K▲ 0% |
Gross Margin % | 25.77% | -10.39% | -31.22% | -12.63% | -43.7% | -37.01% | -51.4% |
Gross Profit Growth % | - | -153.4% | -217.44% | 64.17% | -117.83% | -79% | - |
Operating Expenses | 3.14M | 2.6M | 7.36M | 6.72M | 9.32M | 9.16M | 9.25M |
OpEx % of Revenue | 381.6% | 237.88% | 637.9% | 658.57% | 1450.08% | 674.32% | - |
Selling, General & Admin | 2.38M | 1.8M | 13.84M | 4.66M | 7.86M | 7.65M | 7.79M |
SG&A % of Revenue | 289.14% | 165.05% | 1200.09% | 456.32% | 1221.93% | 562.84% | - |
Research & Development | 307.27K | 642.76K | 1.59M | 2.06M | 1.47M | 1.51M | 1.46M |
R&D % of Revenue | 37.29% | 58.87% | 137.99% | 202.25% | 228.15% | 111.48% | - |
Other Operating Expenses | 454.61K | 152.46K | -8.07M | 0 | 0 | 0 | 0 |
Operating Income | -2.93M▲ 0% | -2.71M▲ 7.6% | -7.71M▼ 184.6% | -6.85M▲ 11.2% | -9.61M▼ 40.2% | -9.67M▼ 0.6% | -9.93M▲ 0% |
Operating Margin % | -355.82% | -248.27% | -669.12% | -671.2% | -1493.78% | -711.33% | -752.99% |
Operating Income Growth % | - | 7.56% | -184.63% | 11.17% | -40.16% | -0.65% | - |
EBITDA | -2.92M | -2.7M | -7.69M | -6.83M | -9.55M | -9.6M | -9.88M |
EBITDA Margin % | -354.14% | -246.95% | -666.96% | -668.46% | -1484.91% | -706.55% | -748.98% |
EBITDA Growth % | - | 7.61% | -185.23% | 11.25% | -39.9% | -0.57% | -2.13% |
D&A (Non-Cash Add-back) | 13.92K | 14.47K | 25K | 28K | 57K | 65K | 53K |
EBIT | -2.93M | -2.75M | -30.43M | -33.75M | -9.98M | -2.73M | -3.41M |
Net Interest Income | 193.55K | -195.38K | -403.31K | -11K | -147K | -67K | -46K |
Interest Income | 193.55K | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 195.38K | 403.31K | 11K | 147K | 67K | 46K |
Other Income/Expense | 110.55K | -230.29K | -22.72M | -26.91M | -522K | 6.87M | 6.58M |
Pretax Income | -2.82M▲ 0% | -2.94M▼ 4.2% | -30.43M▼ 934.9% | -33.76M▼ 10.9% | -10.13M▲ 70.0% | -2.8M▲ 72.4% | -3.35M▲ 0% |
Pretax Margin % | -342.41% | -269.37% | -2639.55% | -3306.76% | -1574.96% | -206.03% | -254.06% |
Income Tax | 0 | 0 | 17K | 18K | 2K | 1K | 1K |
Effective Tax Rate % | 0% | 0% | -0.06% | -0.05% | -0.02% | -0.04% | -0.03% |
Net Income | -2.82M▲ 0% | -2.94M▼ 4.2% | -30.45M▼ 935.4% | -33.78M▼ 10.9% | -10.13M▲ 70.0% | -2.8M▲ 72.3% | -3.35M▲ 0% |
Net Margin % | -342.41% | -269.37% | -2641.02% | -3308.52% | -1575.27% | -206.11% | -254.13% |
Net Income Growth % | - | -4.23% | -935.44% | -10.93% | 70.01% | 72.35% | 66.22% |
Net Income (Continuing) | -2.82M | -2.94M | -30.45M | -33.78M | -10.13M | -2.8M | -3.35M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.19▲ 0% | -0.20▼ 5.3% | -2.51▼ 1155.0% | -4.77▼ 90.0% | -0.36▲ 92.5% | -0.06▲ 83.3% | -0.06▲ 0% |
EPS Growth % | - | -5.26% | -1155% | -90.04% | 92.45% | 83.33% | 87.87% |
EPS (Basic) | -0.19 | -0.20 | -2.51 | -4.77 | -0.36 | -0.06 | - |
Diluted Shares Outstanding | 14.96M | 14.96M | 12.13M | 7.08M | 28.08M | 44.55M | 55.32M |
Basic Shares Outstanding | 14.96M | 14.96M | 12.13M | 7.08M | 28.08M | 44.55M | 55.32M |
Dividend Payout Ratio | - | - | - | - | - | - | - |
ONMD Balance Sheet
OneMedNet Corporation (ONMD) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|
Total Current Assets | 293.62K | 833.29K | 391K | 364.19K | 3.62M | 2.1M | 1.46M |
Cash & Short-Term Investments | 79.18K | 699.32K | 271K | 47.01K | 3.02M | 1.09M | 233K |
Cash Only | 79.18K | 699.32K | 271K | 47.01K | 172K | 585K | 233K |
Short-Term Investments | 0 | 0 | 0 | 0 | 2.85M | 506K | 0 |
Accounts Receivable | 195.37K | 91.74K | 19K | 151.64K | 213K | 495K | 697K |
Days Sales Outstanding | 86.54 | 30.67 | 6.01 | 54.21 | 120.91 | 132.95 | 140.3 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - |
Other Current Assets | 19.07K | 42.23K | 101K | 165.54K | 385K | 509K | 530K |
Total Non-Current Assets | 34.3K | 49.77K | 898K | 98.87K | 108K | 56K | 47K |
Property, Plant & Equipment | 34.3K | 49.77K | 83K | 98.87K | 108K | 56K | 47K |
Fixed Asset Turnover | 24.03x | 21.94x | 13.89x | 10.33x | 5.95x | 24.27x | 22.64x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 815K | 0 | 0 | 0 | 0 |
Total Assets | 327.91K▲ 0% | 883.06K▲ 169.3% | 1.29M▲ 46.0% | 463.06K▼ 64.1% | 3.73M▲ 704.9% | 2.15M▼ 42.3% | 1.51M▲ 0% |
Asset Turnover | 2.51x | 1.24x | 0.89x | 2.20x | 0.17x | 0.63x | 0.70x |
Asset Growth % | - | 169.3% | 45.97% | -64.08% | 704.87% | -42.29% | 3.54% |
Total Current Liabilities | 1.55M | 4.75M | 26.1M | 12.83M | 19.23M | 4.83M | 5.36M |
Accounts Payable | 0 | 0 | 1.18M | 4.18M | 6.37M | 0 | 0 |
Days Payables Outstanding | - | - | 283.94 | 1.33K | 2.52K | - | - |
Short-Term Debt | 1.05M | 3.35M | 24.74M | 4.64M | 8.76M | 350K | 0 |
Deferred Revenue (Current) | 106.37K | 642.35K | 184K | 254K | 561K | 389K | 2.35M |
Other Current Liabilities | 391.12K | 758.82K | 0 | 0 | 283K | 3.79M | 4.68M |
Current Ratio | 0.19x | 0.18x | 0.01x | 0.03x | 0.19x | 0.43x | 0.27x |
Quick Ratio | 0.19x | 0.18x | 0.01x | 0.03x | 0.19x | 0.43x | 0.27x |
Cash Conversion Cycle | - | - | - | - | - | - | 140.3 |
Total Non-Current Liabilities | 1.64M | 1.83M | 1.54M | 489.61K | 449K | 291K | 231K |
Long-Term Debt | 1.55M | 1.55M | 1.5M | 465.02K | 0 | 220K | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 93.19K | 287.61K | 44K | 24.58K | 449K | 71K | 231K |
Total Liabilities | 3.19M | 6.59M | 27.65M | 13.32M | 19.68M | 5.12M | 5.59M |
Total Debt | 2.6M | 4.9M | 26.24M | 5.1M | 8.76M | 570K | 0 |
Net Debt | 2.52M | 4.2M | 25.97M | 5.05M | 8.59M | -15K | -233K |
Debt / Equity | - | - | - | - | - | - | -0.00x |
Debt / EBITDA | - | - | - | - | - | - | -0.00x |
Net Debt / EBITDA | - | - | - | - | - | - | 0.02x |
Interest Coverage | - | -14.05x | -75.46x | -3068.27x | -67.89x | -40.79x | -74.22x |
Total Equity | -2.86M▲ 0% | -5.7M▼ 99.4% | -26.36M▼ 362.2% | -12.86M▲ 51.2% | -15.95M▼ 24.0% | -2.96M▲ 81.4% | -4.08M▲ 0% |
Equity Growth % | - | -99.42% | -362.23% | 51.21% | -24.03% | 81.41% | 309.14% |
Book Value per Share | -0.19 | -0.38 | -2.17 | -1.82 | -0.57 | -0.07 | -0.07 |
Total Shareholders' Equity | -2.86M | -5.7M | -26.36M | -12.86M | -15.95M | -2.96M | -4.08M |
Common Stock | 383 | 434 | 0 | 2.36K | 2K | 2K | 5K |
Retained Earnings | -22.37M | -25.31M | -57.66M | -55.08M | -101.57M | -104.37M | -106.82M |
Treasury Stock | 0 | 0 | 0 | 0 | -529K | -529K | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ONMD Cash Flow Statement
OneMedNet Corporation (ONMD) cash flow — operating, investing & free cash flow history
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|
Cash from Operations | -2.13M | -1.84M | -4.7M | -4.79M | -6.98M | -7.5M | -7.1M |
Operating CF Margin % | -257.88% | -168.94% | -407.89% | -469.25% | -1086% | -552.1% | - |
Operating CF Growth % | - | 13.21% | -154.99% | -1.87% | -45.75% | -7.45% | 2.8% |
Net Income | -2.82M | -2.94M | -30.45M | -33.78M | -10.13M | -2.8M | -3.35M |
Depreciation & Amortization | 13.92K | 14.47K | 25K | 28K | 57K | 65K | 64K |
Stock-Based Compensation | 606.51K | 97.87K | 1.86M | 1.48M | 628K | 2.03M | 1.68M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -234.5K | 0 | 23.89M | 26.88M | 956K | -6.91M | -6.14M |
Working Capital Changes | 310.59K | 984.13K | -29K | 611K | 1.5M | 106K | 654K |
Change in Receivables | -91.89K | 81.09K | 73K | -133K | -61K | -282K | -450K |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 0 | 0 | 1.93M | 717K | 1.49M | 0 | 877K |
Cash from Investing | 0 | -29.94K | -58K | -44K | -1.98M | 2.31M | 739K |
Capital Expenditures | 0 | -29.94K | -58K | -44K | -51K | -13K | -10K |
CapEx % of Revenue | - | 2.74% | 5.03% | 4.31% | 7.93% | 0.96% | 0.76% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -313K |
Cash from Financing | 1.33M | 2.49M | 4.33M | 4.61M | 9.09M | 5.61M | 6.45M |
Debt Issued (Net) | 1.33M | 2.49M | 5.14M | 6.13M | 3.12M | 1.87M | 1.74M |
Equity Issued (Net) | 0 | 0 | -85.72M | 16K | 6.07M | 2.56M | 4.67M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | -88.55M | 0 | -200K | 0 | -11K |
Other Financing | 0 | 0 | 84.92M | -1.53M | -100K | 1.18M | 41K |
Net Change in Cash | -816.05K▲ 0% | 620.14K▲ 176.0% | -428K▼ 169.0% | -224K▲ 47.7% | 125K▲ 155.8% | 413K▲ 230.4% | 89K▲ 0% |
Free Cash Flow | -2.13M▲ 0% | -1.87M▲ 11.8% | -4.76M▼ 154.0% | -4.83M▼ 1.6% | -7.03M▼ 45.5% | -7.52M▼ 6.9% | -7.11M▲ 0% |
FCF Margin % | -257.88% | -171.68% | -412.92% | -473.56% | -1093.93% | -553.05% | -538.82% |
FCF Growth % | - | 11.8% | -154.01% | -1.55% | -45.48% | -6.85% | 4.4% |
FCF per Share | -0.14 | -0.13 | -0.39 | -0.68 | -0.25 | -0.17 | -0.13 |
FCF Conversion (FCF/Net Income) | 0.75x | 0.63x | 0.15x | 0.14x | 0.69x | 2.68x | 2.12x |
Interest Paid | 0 | 0 | 0 | 0 | 26K | 23K | -10K |
Taxes Paid | 0 | 0 | 0 | 0 | 18K | 1K | 1K |
ONMD Key Ratios
OneMedNet Corporation (ONMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | - | - | - | 90.45% |
Return on Invested Capital (ROIC) | - | - | - | - | - | 199.41% |
Gross Margin | -10.39% | -31.22% | -12.63% | -43.7% | -37.01% | -51.4% |
Net Margin | -269.37% | -2641.02% | -3308.52% | -1575.27% | -206.11% | -254.13% |
Debt / Equity | - | - | - | - | - | -0.00x |
Interest Coverage | -14.05x | -75.46x | -3068.27x | -67.89x | -40.79x | -74.22x |
FCF Conversion | 0.63x | 0.15x | 0.14x | 0.69x | 2.68x | 2.12x |
Revenue Growth | 32.49% | 5.61% | -11.45% | -37.02% | 111.35% | 147.93% |
Related:ONMD Dividend History·ONMD Revenue History·ONMD Price History·ONMD P/E History·ONMD Financial Ratios·ONMD Institutional Holders
ONMD SEC Filings & Documents
OneMedNet Corporation (ONMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
ONMD Frequently Asked Questions
OneMedNet Corporation (ONMD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
OneMedNet Corporation (ONMD) reported $1.3M in revenue for fiscal year 2025. This represents a 60% increase from $0.8M in 2020.
OneMedNet Corporation (ONMD) grew revenue by 111.4% over the past year. This is strong growth.
OneMedNet Corporation (ONMD) reported a net loss of $3.4M for fiscal year 2025.
Dividend & Returns
OneMedNet Corporation (ONMD) had negative free cash flow of $7.1M in fiscal year 2025, likely due to heavy capital investments.